High frequency of IL‐4 producing helper T lymphocytes associated with a reduced incidence of heart allograft rejection

The reduction in the frequency of rejection episodes several months after heart transplantation (HTX) correlates with the development of donor‐specific nonresponsiveness. This is reflected in a reduced frequency of donor‐specific cytotoxic T cells (CTL) in the peripheral blood. We investigated wheth...

Full description

Saved in:
Bibliographic Details
Published inTransplant international Vol. 13; no. S1; pp. S216 - S224
Main Authors Hoffen, E., Polen, E., Robertus‐Teunissen, M., Jonge, N., Lahpor, J.R., Gmelig‐Meyling, F.H.J., Weger, R.A.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.06.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The reduction in the frequency of rejection episodes several months after heart transplantation (HTX) correlates with the development of donor‐specific nonresponsiveness. This is reflected in a reduced frequency of donor‐specific cytotoxic T cells (CTL) in the peripheral blood. We investigated whether the reduced CTL frequency and the incidence of rejection episodes coincided with a change in the frequency of either IL‐2‐ or IL‐4‐producing helper T lymphocytes (HTL). We measured the frequency of HTL before and at several time points after HTX in the blood of ten recipients, using limiting dilution analysis for IL‐2 and IL‐4. In most patients, HTL frequencies dropped immediately after transplantation, but returned to pre‐HTX values later after transplantation. No consistent decrease or increase in frequencies was observed long after HTX. In contrast to IL‐2, the HTL frequencies for IL‐4 before transplantation were significantly higher in patients without post‐HTX rejection episodes requiring treatment than in patients with such episodes. This phenomenon was observed for the in vitro responses towards both donor and third‐party cells. In conclusion, relatively high frequencies of IL‐4‐producing T cells may have a beneficial effect on the outcome of human heart transplantation, because they are associated with a reduced incidence of rejection episodes after transplantation.
Bibliography:Department of Dermatology/Allergology, University Medical Centre Utrecht (University Hospital Utrecht), P.O. Box 85.500, 3508 GA Utrecht, The Netherlands
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0934-0874
1432-2277
DOI:10.1111/j.1432-2277.2000.tb02023.x